March 07, 2014
Eli Lilly & Co. argued Thursday that the first federal bellwether trial over the bladder cancer risks of diabetes drug Actos should exclude evidence about its fines for marketing the antipsychotic drug Zyprexa, saying it's not relevant to negligent marketing claims over Actos.
March 03, 2014
A former Eli Lilly & Co. employee lied on the witness stand during the first federal bellwether trial over allegations that the diabetes drug Actos causes bladder cancer, plaintiffs said Friday, asking a Louisiana federal court to enter judgment against the company as a penalty.